Clinical Trial: Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618299) titled 'Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women' on May 08.

Brief Summary: Evaluation of the Excretion of Fosfomycin into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Lactating Women

Intervention: DRUG: ZTI-01

Participants will receive a single intravenous dose of ZTI-01 (6 g)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Meitheal Pharmaceuticals, Inc.

Published by HT Digital Content Services with permission from H...